@vhpmanorak
Exciting news from Eli Lilly! On March 20, 2025, they rolled out their new diabetes and obesity management medication, Mounjaro (tirzepatide), now in a convenient single-dose vial, after getting the green light from CDSCO. For adults managing these conditions, this is a significant step forward.